nelfinavir has been researched along with Liver Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Boukeileh, S; Darawshi, O; Dipta, P; Fassler, R; Huber, M; Karni, R; Mahameed, M; McLennan, G; Obiedat, A; Preisinger, C; Reichmann, D; Rimon, A; Tirosh, B; Wilhelm, T | 1 |
| Bogaerts, E; Coucke, C; Devisscher, L; Geerts, A; Laukens, D; Libbrecht, L; Paridaens, A; Raevens, S; Van Steenkiste, C; Van Vlierberghe, H; Vandewynckel, YP; Vandierendonck, A; Verhelst, X | 1 |
| Hao, J; Niu, L; Sun, L; Wang, H; Wang, P; Zhu, X | 1 |
3 other study(ies) available for nelfinavir and Liver Neoplasms
| Article | Year |
|---|---|
Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy.
Topics: Acetamides; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; CRISPR-Cas Systems; Cyclohexylamines; eIF-2 Kinase; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Gene Knockout Techniques; Golgi Apparatus; Humans; Liver Neoplasms; Male; Membrane Proteins; Mice; Molecular Chaperones; Nelfinavir; Xenograft Model Antitumor Assays | 2020 |
Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Cinnamates; Drug Synergism; Endoplasmic Reticulum Stress; Humans; Liver Neoplasms; Mice; Nelfinavir; Oligopeptides; Proteasome Inhibitors; Thiourea; Tunicamycin; Unfolded Protein Response; Xenograft Model Antitumor Assays | 2016 |
Antitumour effects of a protease inhibitor, nelfinavir, in hepatocellular carcinoma cancer cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; HIV Protease Inhibitors; Humans; Liver Neoplasms; Nelfinavir | 2012 |